
Neurotech
NTI.AXNeurotech International Limited Price (NTI.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
911,961,998
(14.1705)%Description
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands,... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.028-0.12
- Market Cap 36.47M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Devices
- ceo: Dr. Anthony Filippis M.B.A., Ph.D.
- IPO Date: November, 03, 2016
- Country: AU
- Currency: AUD
- Headquaters: Nedlands, WA
- Employees: 18
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
